Beta-Blockers in Heart Failure: Mechanisms, Efficacy, and Clinical Applications

Authors

  • Swaroop Lahoti

Abstract

Heart failure (HF) is a complex clinical syndrome characterized by the heart's inability to pump sufficient blood to meet the body's metabolic demands. It can result from various cardiac conditions, including ischemic heart disease, hypertension, and cardiomyopathies. The prevalence of heart failure is increasing globally, affecting millions of individuals and leading to significant morbidity and mortality. Patients often present with symptoms such as dyspnea, fatigue, and fluid retention, which severely impact their quality of life.

Author Biography

Swaroop Lahoti

Author Details:

Dr. Swaroop Lahoti,

Department of Pharmaceutics,

Y B Chavan College of Pharmacy,

Chhatrapati Sambhajinagar - 431 001,

Maharashtra, India.

E-mail: [email protected]

Published

2021-06-09
Statistics
Abstract Display: 210
PDF Downloads: 86

How to Cite

Swaroop Lahoti. “Beta-Blockers in Heart Failure: Mechanisms, Efficacy, and Clinical Applications”. Innovations in Pharmacy Planet, vol. 9, no. 2, June 2021, pp. 24-28, https://www.innovationaljournals.com/index.php/ip/article/view/973.

Issue

Section

Editorial